Australia's NSW Cancer Council goes rap to promote skin cancer awareness.

width="425" height="344">

Paying doctors to do more isn't in a cancer patient's best interest.

An oncologist pens a brutally frank letter discussing how the current fee for service system influences the decisions when administering chemotherapy.

Currently, up to 70 percent of a cancer doctor's earnings come from the sale of chemotherapy drugs. There is a strong financial incentive from "doing more," and doctors are not immune to this allure. ...

Read more...

Colonoscopies are considered the gold standard for colon cancer screening.

MedPage Today reports a recent study from the Annals of Internal Medicine, that suggests it's much less accurate than initially thought. The problem was with detecting right-sided cancers, where "the test missed just about every cancer in the right side of the colon, where cancers are harder to detect but about 40 percent arise. And it also ...

Read more...

The USPSTF recently advised against screening men older than age 75 for prostate cancer.

Is that recommendation sound? The NEJM has a nice perspective piece detailing the reasons why.

Some interesting points here.

First, efficacy for treatment in men aged 75 or older is questionable at best, as "18 radical prostatectomies would have to be performed to prevent a single death from prostate cancer over ...

Read more...

The USPSTF recently updated their cancer screening guidelines, recommending against prostate cancer screening in men older than 75.

Toni Brayer recaps the controversy surrounding the PSA test. With a Democratic-controlled government, a push is going to be made for a comparative effectiveness institute. There is a real possibility that the dogma of "more screening equals better medicine" will be challenged.

Patients are going to face ...

Read more...

Gary Schwitzer writes a nice piece on the hype surrounding cancer screening tests. Evidence-based guidelines from the USPSTF are often ignored by mainstream media, who write pieces glamorizing the latest, largely unproven, cancer screening modalities. Here are some reminders for journalists:

* Newer isn't always better.
* More isn't always better.
* Screening doesn't make sense for everyone.
* Many screening tests do good; many ...

Read more...

Most Popular

SUBSCRIBE 
close-link
Get KevinMD's 5 most popular stories
Subscribe. It's free.
close-image